Thursday, 7 November 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 07 November 2024
News

AI boom to favour early adopters

Posted 7 November 2024 AM

Investment in generative artificial intelligence in the pharmaceutical industry will boom over the next few years, giving a competitive advantage to early adopters, according to S&P Global.

In a report, S&P Global Ratings AI in Pharmaceuticals Promises Innovation, Speed and Savings, the analysts noted that all larger pharmas either have proprietary AI platforms used in research, or use third-party solutions integrated into their R&D. They're also partnering with smaller AI-driven pharmas to accelerate drug discovery processes.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (15)

Access & Reimbursement (1)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.